BROMO SELTZER 2.667 G / 7.3 G
CITRIC ACID : 2.667 G / 7.3 G SODIUM BICARBONATE : 3.683 G / 7.3 G · DIN 02241892 · TOWER LABORATORIES LTD
Health Canada status: CANCELLED POST MARKET
What is BROMO SELTZER?
BROMO SELTZER 2.667 G / 7.3 G contains CITRIC ACID : 2.667 G / 7.3 G SODIUM BICARBONATE : 3.683 G / 7.3 G. It is listed in the Health Canada Drug Product Database under DIN 02241892, held by TOWER LABORATORIES LTD, supplied as GRANULES for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Aug-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02241892 |
|---|---|
| Brand name | BROMO SELTZER |
| Generic / active ingredient | CITRIC ACID : 2.667 G / 7.3 G SODIUM BICARBONATE : 3.683 G / 7.3 G |
| Manufacturer | TOWER LABORATORIES LTD |
| Strength | 2.667 G / 7.3 G |
| Dosage form | GRANULES |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02AH ANTACIDS WITH SODIUM BICARBONATE |
| AHFS class | 56:04.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Aug-2009 |
| Original market date | 2000-08-21 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A02AH ANTACIDS WITH SODIUM BICARBONATE. 0 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BAKING SODA USP | 100 % | POWDER | REGAL PHARMS, DIVISION OF BRADCAN CORPORATION | CANCELLED POST MARKET | DIN 00641634 |
| BRIOSCHI EFFERVESCENT ANTACID - 1.8GM/6GM | 1.8 G / 6 G | POWDER (EFFERVESCENT) | BRIOSCHI, INC. | CANCELLED POST MARKET | DIN 02230226 |
| BRIOSCHI EFFERVESCENT ANTACID PWR 280.3MG/GM | 269 MG | POWDER (EFFERVESCENT) | BRIOSCHI, INC. | CANCELLED POST MARKET | DIN 00677450 |
| NORMO GASTRYL | 195 MG | TABLET (EFFERVESCENT) | SABEX INC | CANCELLED POST MARKET | DIN 00570826 |
| OHTA'S ISAN STOMACH POWDER | 497 MG / 1.3 G | POWDER | MAIZUN-CALBER (CANADA) LTD. | CANCELLED POST MARKET | DIN 02005085 |
| ROTER TABLETS | 25 MG | TABLET | ROTER PHARMACEUTISCHE FABRIEK | CANCELLED POST MARKET | DIN 00173797 |
| SODIUM BICARBONATE TAB 300MG | 300 MG | TABLET | D.C. LABS LIMITED | CANCELLED POST MARKET | DIN 00093068 |
| SODIUM BICARBONATE TAB 600MG | 600 MG | TABLET | D.C. LABS LIMITED | CANCELLED POST MARKET | DIN 00221619 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.